| Danielle Leigh Blair, PHARMD | |
|
3000 Ericsson Dr Ste 100, Warrendale, PA 15086-6501 | |
| (724) 772-6000 | |
| (901) 473-5051 |
| Full Name | Danielle Leigh Blair |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3000 Ericsson Dr Ste 100, Warrendale, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265764336 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP441144 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Leigh Blair, PHARMD 3000 Ericsson Dr Ste 100, Warrendale, PA 15086-6501 Ph: (724) 772-6000 | Danielle Leigh Blair, PHARMD 3000 Ericsson Dr Ste 100, Warrendale, PA 15086-6501 Ph: (724) 772-6000 |
News Archive
Remember that slim kid in school - the one with the cook-from-scratch mom? He's likely one of the fittest dudes at your high school reunion according to new research from Cornell University, published online in the journal PLOS ONE.
Federal disability benefits can lead to increases in other support for beneficiaries, such as in-kind assistance from adult children, according to a new RAND Corporation study.
A preliminary report suggests that cell-free fetal messenger RNA (ribonucleic acid) can be extracted from amniotic fluid (fluid around the fetus), and then be analyzed to study gene expression changes that may reflect the well-being of the fetus, according to a paper in the February 16 issue of JAMA, a theme issue on medical applications of biotechnology.
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
› Verified 4 days ago
Hilary Szczypiorski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 Pennwood Pl, Suite 300, Warrendale, PA 15086 Phone: 724-779-4720 Fax: 724-779-4720 | |
Colleen Straub, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Ericsson Dr Ste 100, Warrendale, PA 15086 Phone: 724-272-4509 | |
Kelsey Thompson, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 Pennwood Pl, Suite 300, Warrendale, PA 15086 Phone: 855-779-4720 Fax: 855-779-4721 | |
Jill A. Felicetti, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Ericsson Dr Ste 100, Warrendale, PA 15086 Phone: 724-772-6000 Fax: 901-435-4603 | |
Iris Rizk, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Ericsson Dr Ste 100, Warrendale, PA 15086 Phone: 724-772-6000 | |
Melissa Leigh Toy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Ericsson Dr Ste 100su, Warrendale, PA 15086 Phone: 724-772-6000 | |
Mr. David Frank Senko, MS, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Ericsson Dr Ste 3000, Warrendale, PA 15086 Phone: 724-772-6000 |